ChartRow logo
Share this page
IDYA
$32.85-2.95%
as of close, Oct 16, 2026
☾ AH $32.85 -2.95%
PeersMRNALLYMDTUNHJNJTMO

IDEAYA Biosciences Inc. trailing returns

How IDEAYA Biosciences Inc. (IDYA) has performed over the last day, week, month and year, over 5 years, and since inception, through October 16, 2026 — price return and dividends side by side, with the worst drop inside each window.

Trailing returns by period#

To 2026-10-16. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.

PeriodPriceDivsTotalWorst drop
1 day-3.0%+0.0%-3.0%—
5 days-9.0%+0.0%-9.0%-9.0%Oct 16
1 month-12.9%+0.0%-12.9%-17.3%Oct 16
YTD-5.0%+0.0%-5.0%-27.1%Jun 10
1 year+18.6%+0.0%+18.6%-27.1%Jun 2026
5 years+7.3%+0.0%+7.3%+42.0%-69.2%Apr 2025
Since inception (2019)+15.7%+0.0%+15.7%+193.6%-74.6%Mar 2020

Growth of IDYA#

Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.

  • 5 years+7.3%/year · +42.0%

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-10-16). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in IDYA's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

FAQ#

What is IDEAYA Biosciences Inc.'s return since inception?
Since 2019, IDEAYA Biosciences Inc. (IDYA) has compounded at about +15.7% a year — +193.6% in total.

More on IDEAYA Biosciences Inc.